ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer.

Kari B Wisinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.